See also this year's filing and all EDGAR filings for this company.
PDF Report 0001107421_2018_Alaunos_Therapeutics_Inc.pdf
Logs
| warning | Ignoring company because Expenses is zero | pre-agg | {'balance_sheet': {'company_id': '0001107421', 'EntityCommonStockSharesOutstanding': 142398936, 'Assets': 105606000, 'AssetsCurrent': 90783000, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 58420000, 'LiabilitiesAndStockholdersEquity': 105606000, 'LiabilitiesCurrent': 20856000, 'LiabilitiesNoncurrent': 0, 'NetIncome': -54323000, 'PropertyPlantAndEquipmentNet': 1211000, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'TemporaryEquity': 0, 'remainder_Assets': 13612000, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 37564000, 'remainder_LiabilitiesAndStockholdersEquity': -96806000, 'remainder_NetIncome': -54323000, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001107421')"} |
Edgar->Model Mapping
